| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.86 | 0.0003 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |